A Resolution Recognizing The First Week Of May 2023 As Tardive Dyskinesia Awareness Week In Arkansas.
Impact
The resolution emphasizes the importance of awareness and recognition of tardive dyskinesia, advocating for regular screening and increased understanding among healthcare professionals and the public. It aligns with recommendations from the American Psychiatric Association, which calls for heightened awareness of the condition due to its often-misdiagnosed nature. Promoting an awareness week can be beneficial in educating both patients and providers about the risks associated with antipsychotic medications and the potential for developing tardive dyskinesia.
Summary
House Resolution 1063 recognizes the first week of May 2023 as Tardive Dyskinesia Awareness Week in Arkansas. This resolution aims to bring attention to tardive dyskinesia, a movement disorder that can occur as a side effect of medications used to treat chronic mental illnesses, such as schizophrenia and bipolar disorder. The resolution cites the significant number of Americans affected by this condition, estimating that over 600,000 individuals suffer from it, with a notable prevalence among those receiving long-term antipsychotic treatment.
Contention
While the resolution does not have laws to enforce, its passage reflects broader aims to improve mental health treatment and awareness. The recognition of an awareness week may also lead to discussions on funding for research and initiatives aimed at better understanding and treating tardive dyskinesia. Importantly, the resolution encourages legislative support for mental health issues, which could pave the way for future discussions and potential legislation that address the challenges faced by individuals with movement disorders stemming from necessary medical treatments.